[MDGL] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
06-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- -2.57%
YoY- -17.76%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 0 0 0 0 1,664 3,383 130,405 -
PBT -17,628 -19,966 -22,515 -14,996 -12,734 -10,262 118,119 -
Tax 0 0 0 0 0 31 0 -
NP -17,628 -19,966 -22,515 -14,996 -12,734 -10,262 118,119 -
Tax Rate - - - - - - 0.00% -
Total Cost 17,628 19,966 22,515 14,996 14,398 13,645 12,286 6.19%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin 0.00 0.00 0.00 0.00 -765.26 -303.34 90.58 -
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -102.46 -6.61 -11.41 -8.65 -9.02 -8.89 122.15 -
EPS Diluted -102.46 -6.61 -11.41 -8.65 -9.02 -8.89 121.80 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.